newsfilter
← Latest News
PR Newswire·

INOVIO Announces Pricing of Approximately $75 Million Public Offering

INO
  • INOVIO Pharmaceuticals priced a public offering of 58,747,235 common stock shares at $1.05 per share & pre-funded warrants for 12,681,337 shares at $1.049 per warrant.
  • The company granted underwriters a 30-day option to purchase up to 10,714,285 additional shares at the same offering price.
  • Gross proceeds from the offering are expected to be approximately $75 million before deducting underwriting discounts, commissions, & expenses.
  • The offering is scheduled to close on or about November 9, 2026, subject to customary closing conditions.
  • Jefferies & Piper Sandler are acting as joint book-running managers, with H.C. Wainwright & Co. serving as the lead manager.
  • The sale is conducted via a shelf registration statement filed with the SEC on July 2, 2026, which was declared effective on July 10, 2026.
  • All securities in the offering are being sold by INOVIO Pharmaceuticals, Inc.
Company
INOVIO Pharmaceuticals, Inc.
Keywords
INOVIO Pharmaceuticals, Inc.